Iron overload as a risk factor for poor graft function following allogeneic hematopoietic stem cell transplantation

被引:4
作者
Wu, Xue-Qiong [1 ]
Lin, Kang-Ni [1 ]
Chen, Min-Min [1 ]
Jiang, Pei-Fang [1 ]
Zhang, Yu-Xin [1 ]
Chen, Yong-Quan [1 ]
Chen, Qiu-Ru [1 ]
Xiao, Min [1 ]
Zhu, Hao-Jie [1 ]
Issa, Hajji Ally [1 ]
Chen, Shao-Zhen [1 ]
Luo, Xiao-Feng [1 ]
Ren, Jin-Hua [1 ]
Li, Qian [2 ]
Zeng, Yan-Ling [1 ]
Xu, Jing-Jing [1 ]
Lin, Yi-Feng [1 ]
Zheng, Rong [1 ]
Zheng, Zhi-Hong [1 ]
Chen, Zhi-Zhe [1 ]
Hu, Jian-Da [1 ]
Yang, Ting [1 ]
机构
[1] Fujian Med Univ, Fujian Prov Key Lab Hematol, Fujian Inst Hematol, Dept Hematol,Union Hosp, 29 Xinquan Rd, Fuzhou 350001, Fujian, Peoples R China
[2] Fujian Med Univ, Affiliated Nanping Hosp 1, Dept Hematol, Nanping, Fujian, Peoples R China
基金
中国国家自然科学基金;
关键词
allogeneic hematopoietic stem cell transplantation; bone marrow microenvironment; hematopoietic reconstruction; iron overload; poor graft function; BONE-MARROW; ASSOCIATION; SURVIVAL; NICHE;
D O I
10.1002/kjm2.12238
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hematological malignancies are increasingly treated with allogeneic hematopoietic stem cell transplantation (allo-HSCT). Unfortunately, iron overload is a frequent adverse effect of allo-HSCT and is associated with poor prognosis. In the present study, we investigated hematopoiesis in iron-overloaded mice and elucidated the effects of iron overload on the bone marrow (BM) microenvironment. Iron-overloaded BALB/C mice were generated by injecting 20 mg/mL saccharated iron oxide intraperitoneally. Hematoxylin-eosin staining was performed to evaluate the effects of an iron overload in mice. BM cells obtained from C57BL/6 mice were transplanted into irradiated BALB/C mice (whole-body irradiation of 4 Gy, twice with a 4-hours interval) by tail vein injection. Two weeks after allo-HSCT, the hematopoietic reconstitution capacity was evaluated in recipients by colony-forming assays. Histopathological examinations showed brown-stained granular deposits, irregularly arranged lymphocytes in the liver tissues, and blue-stained blocks in the BM collected from mice received injections of high-dose saccharated iron oxide (20 mg/mL). Iron-overloaded mice showed more platelets, higher-hemoglobin (HGB) concentration, fewer granulocyte-macrophage colony-forming units (CFU-GM), erythrocyte colony-forming units (CFU-E), and mixed granulocyte/erythrocyte/monocyte/megakaryocyte colony-forming units (CFU-mix) than healthy mice. Iron-overloaded recipients presented with reduced erythrocytes and HGB concentration in peripheral blood, along with decreased marrow stroma cells, CFU-GM, CFU-E, and CFU-mix relative to healthy recipients. Taken together, our findings demonstrate that iron overload might alter the number of red blood cells after transplantation in mice by destroying the BM microenvironment, thereby affecting the recovery of BM hematopoietic function.
引用
收藏
页码:825 / 833
页数:9
相关论文
共 50 条
  • [41] CD34+ selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation
    Mainardi, Chiara
    Ebinger, Martin
    Enkel, Sigrid
    Feuchtinger, Tobias
    Teltschik, Heiko-Manuel
    Eyrich, Matthias
    Schumm, Michael
    Rabsteyn, Armin
    Schlegel, Patrick
    Seitz, Christian
    Schwarze, Carl-Phillip
    Mueller, Ingo
    Greil, Johann
    Bader, Peter
    Schlegel, Paul-Gerhardt
    Martin, David
    Holzer, Ursula
    Doering, Michaela
    Handgretinger, Rupert
    Lang, Peter
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (01) : 90 - 99
  • [42] Cytomegalovirus is a potential risk factor for late-onset hemorrhagic cystitis following allogeneic hematopoietic stem cell transplantation
    Han, Ting-Ting
    Xu, Lan-Ping
    Liu, Dai-Hong
    Liu, Kai-Yan
    Fu, Hai-Xia
    Zhao, Xiang-Yu
    Zhao, Xiao-Su
    Huang, Xiao-Jun
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (01) : 55 - 61
  • [43] Kinetics of iron removal by phlebotomy in patients with iron overload after allogeneic hematopoietic cell transplantation
    Eisfeld, Ann-Kathrin
    Krahl, Rainer
    Jaekel, Nadja
    Niederwieser, Dietger
    Al-Ali, Haifa Kathrin
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2012, 2 (04): : 243 - 253
  • [44] Iron overload, hematopoietic cell transplantation, and graft-versus-host disease
    Deeg, H. Joachim
    Spaulding, Emily
    Shulman, Howard M.
    LEUKEMIA & LYMPHOMA, 2009, 50 (10) : 1566 - 1572
  • [45] Monocytes as an early risk factor for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Sun, Huimin
    Wu, Linjie
    Zhao, Xueying
    Huo, Yingying
    Dong, Peiyuan
    Pang, Aiming
    Zheng, Yawei
    Han, Yiwen
    Ma, Shihui
    Jiang, Erlie
    Dong, Fang
    Cheng, Tao
    Hao, Sha
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [46] Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantation
    Watz, Emma
    Remberger, Mats
    Ringden, Olle
    Ljungman, Per
    Sundin, Mikael
    Mattsson, Jonas
    Uhlin, Michael
    TRANSFUSION, 2015, 55 (10) : 2339 - 2350
  • [47] Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis
    Servais, Sophie
    Baron, Frederic
    Lechanteur, Chantal
    Seidel, Laurence
    Baudoux, Etienne
    Briquet, Alexandra
    Selleslag, Dominik
    Maertens, Johan
    Poire, Xavier
    Schroyens, Wilfried
    Graux, Carlos
    De Becker, Ann
    Zachee, Pierre
    Ory, Aurelie
    Herman, Julie
    Kerre, Tessa
    Beguin, Yves
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [48] Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation
    Haen, Sebastian P.
    Schumm, Michael
    Faul, Christoph
    Kanz, Lothar
    Bethge, Wolfgang A.
    Vogel, Wichard
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (12) : 2241 - 2251
  • [49] Clinical features, pathophysiology, and therapy of poor graft function post-allogeneic stem cell transplantation
    Prabahran, Ashvind
    Koldej, Rachel
    Chee, Lynette
    Ritchie, David
    BLOOD ADVANCES, 2022, 6 (06) : 1947 - 1959
  • [50] Allogeneic hematopoietic stem cell transplantation
    Kai, S
    Hara, T
    THERAPEUTIC APHERESIS AND DIALYSIS, 2003, 7 (03) : 285 - 291